Zydus Cadila gets USFDA nod to market anti-inflammatory drug Industry-The Economic Times — June 20, 2017 comments off The product is a nonsteroidal anti-inflammatory drug and will be produced at the group’s formulations manufacturing facility at Baddi, Zydus Cadila said.